Menu
Menu

Read How Zephyr® Valves Have Changed Lives

Successful-Patient-Zephyr-Treatment

Read How Zephyr® Valves Have Changed Lives

The Zephyr Valve Improves Patients’ Quality of Life and Allows Them to Do More1

Hear from people who took control of their severe COPD/emphysema and got back to living life on their terms with the Zephyr Valve.

Please review the safety information provided on this site. Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

See How Patients Feel After the Zephyr Valve Treatment

Please review the safety information provided on this site. Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

Learn More About the Zephyr Valve

  • You are opting in to receive future communications about COPD/emphysema and the Zephyr Valve.
US-EN-1019-v1

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. Complications of treatment can include but are not limited to pneumothorax (tear in the lung), worsening of COPD symptoms, hemoptysis, pneumonia, and, in rare cases, death. The Zephyr Valve is contraindicated in patients who have not quit smoking or are allergic to Nitinol (nickel-titanium). Please talk with your physician about other contraindications, warnings, precautions, and adverse events. Only a trained physician can decide whether a particular patient is an appropriate candidate for treatment with the Zephyr Valve.

© 2021-Present Pulmonx Corporation or its affiliates.  All rights reserved. All trademarks are property of their respective owners.

Site Designed by The Deciding Factor, Inc.

Patient Stories

Follow Us

Follow Us

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. Complications of treatment can include but are not limited to pneumothorax (tear in the lung), worsening of COPD symptoms, hemoptysis, pneumonia, and, in rare cases, death. The Zephyr Valve is contraindicated in patients who have not quit smoking or are allergic to Nitinol (nickel-titanium). Please talk with your physician about other contraindications, warnings, precautions, and adverse events. Only a trained physician can decide whether a particular patient is an appropriate candidate for treatment with the Zephyr Valve.

© 2021-Present Pulmonx Corporation or its affiliates.  All rights reserved. All trademarks are property of their respective owners.

Site Designed by The Deciding Factor, Inc.

Patient Stories